HR 6980 United States House · 117th Congress

To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.

Summary
This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 8, 2022 Last action Mar 9, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Mar 9, 2022
Committee
Referred to the Subcommittee on Health.
lower
Mar 8, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 8, 2022
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors